Intellia Therapeutics NTLA
NASDAQ NTLA
$11.21 +0.05 (+0.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

Intellia Therapeutics (NTLA) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Intellia Therapeutics 1.57 Bn -205.07 Mn - 80.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.54 Mn
Mar 31, 2026 113.35 Mn
Dec 31, 2025 94.71 Mn
Sep 30, 2025 115.94 Mn
Jun 30, 2025 162.75 Mn
Mar 31, 2025 178.27 Mn
Dec 31, 2024 321.65 Mn
Sep 30, 2024 199.67 Mn
Jun 30, 2024 277.63 Mn
Mar 31, 2024 267.97 Mn
Dec 31, 2023 197.23 Mn
Sep 30, 2023 213.20 Mn
Jun 30, 2023 213.05 Mn
Mar 31, 2023 263.62 Mn
Dec 31, 2022 210.19 Mn
Sep 30, 2022 212.80 Mn
Jun 30, 2022 130.85 Mn
Mar 31, 2022 93.73 Mn
Dec 31, 2021 94.61 Mn
Sep 30, 2021 192.49 Mn
API Access

Intellia Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NTLA&period=max&api_key=YOUR_API_KEY